share_log

绿叶制药(02186):1类新药LY 03005的III期临床结果于2022年美国精神病学协会(APA)年会发布

Zhitong Finance ·  Jun 8, 2022 11:40

智通财经APP讯,绿叶制药(02186)发布,集团自主研发的中国1类化学新药(LY 03005)的III期临床结果于2022年美国精神病学协会( American Psychiatric Association, APA )年会上发布。

公告称,APA是全球最大的精神病学协会,其年会为每年精神科领域的顶级学术研究会议之一,聚焦于精神病学的突破性研究、临床进展及该领域内的热点话题。此次LY 03005的III期临床数据亮相APA年会,彰显其作为中国塬创1类新药对于抑郁症治疗的作用与意义,在获得国际学术认可的路上迈出重要一步。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 346

Recommended

Write a comment

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.